Back to Search
Start Over
Evaluation of the rabbit Purkinje fibre assay as an in vitro tool for assessing the risk of drug-induced torsades de pointes in humans.
- Source :
-
Drug safety [Drug Saf] 2006; Vol. 29 (3), pp. 237-54. - Publication Year :
- 2006
-
Abstract
- Background: The issue of drug-induced QT interval prolongation and torsades de pointes represents a major concern for pharmaceutical development. In this investigation, we examined the value of the isolated rabbit Purkinje fibre as an in vitro action potential (AP) assay to predict the potential of drugs to induce these undesirable adverse effects.<br />Methods: First, we categorised the proarrhythmic risk of 26 medicinal products based on proportional reporting ratios for these two adverse events recorded in a US FDA database (Spontaneous Reporting System/Adverse Event Reporting System). Second, we measured drug effects on AP in rabbit Purkinje fibres. Finally, the results of the two analyses were compared to evaluate the predictive value of the in vitro assay.<br />Results: Analysis of the clinical data classified the drugs into 14 positive, 7 negative and 5 questionable for proarrhythmic risk. Based on in vitro electrophysiological profiles, the drugs were grouped into four categories: (i) profile 1 drugs prolong repolarisation without slowing depolarisation; (ii) profile 2 drugs prolong repolarisation and also slow depolarisation; (iii) profile 3 drugs shorten repolarisation; and (iv) profile 4 drugs are without effects. All 14 clinical-positive drugs fell into profiles 1 or 2 (prolongers) with low safety margins (except probucol, which showed no effect, probably because of its low solubility). Clinical-negative drugs belonged mostly to profiles 3 or 4 (non-prolongers) [except clemastine and amlodipine, which were prolongers but had large safety margins]. Clinical-questionable drugs either did not prolong or prolonged slightly but produced additional electrophysiological effects opposing prolongation.<br />Conclusion: The rabbit Purkinje fibre is a valuable assay for evaluating the proarrhythmic liability of pharmaceuticals as it can reveal complex electrophysiological profiles that modulate repolarisation delay.
- Subjects :
- Action Potentials drug effects
Animals
Anti-Inflammatory Agents, Non-Steroidal adverse effects
Antipsychotic Agents adverse effects
Cardiovascular Agents adverse effects
Female
Histamine H1 Antagonists adverse effects
Humans
In Vitro Techniques
Long QT Syndrome chemically induced
Purkinje Fibers physiology
Rabbits
Risk
Torsades de Pointes physiopathology
Drug Evaluation, Preclinical methods
Heart drug effects
Predictive Value of Tests
Purkinje Fibers drug effects
Torsades de Pointes chemically induced
Subjects
Details
- Language :
- English
- ISSN :
- 0114-5916
- Volume :
- 29
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Drug safety
- Publication Type :
- Academic Journal
- Accession number :
- 16524323
- Full Text :
- https://doi.org/10.2165/00002018-200629030-00007